$CRH

Citigroup Adjusts Price Target on CRH public to $122 From $138, Maintains Buy Rating

Citigroup lowered its price target on CRH public to $122 from $138 while keeping a Buy rating, according to the note cited in the article. The stock was shown around $95.64 at 11:18am EDT. Stephens also adjusted its target to $125 from $135, maintaining an Overweight rating.

Original reporting
Published Jul 31, 2026, 3:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 3:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CRH
Neutral
low confidence
Mentioned
$CRH
Relevance
4/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CRHNeutralLow
01

Why it matters

For trading, the actionable element is the PT reduction, but the article does not include new company disclosures or quantified fundamental changes.

02

Market read

This is primarily a valuation-target update, offering limited incremental information beyond the PT cut.

03

What to watch

The article lacks the underlying thesis for the PT change, so traders cannot assess whether the downgrade is driven by earnings revisions, multiples, or risk assumptions.

Relevance 4/10Novelty 3/10Timing: today (published 07/31/2026)

Background

The article is a sell-side update summarizing Citigroup’s revised price target and rating for CRH.

Company-level read

Ticker impact

$CRHNeutralLow confidence
Context

Citigroup cut CRH’s price target to $122 from $138 while keeping a Buy rating, signaling a valuation reset for the stock.

Expected impact

Likely modest near-term pressure or capped upside versus prior PT expectations, but not a standalone catalyst.

Evidence & confidence

The body provides only the PT change and rating maintenance, with no new earnings, guidance, or company-specific operational update.

Market effects

Limited sector read-through because the article contains only a single sell-side PT adjustment, not sector-wide data.

No explicit regional catalyst beyond the analyst note.

No global macro or cross-border transaction details provided.

Counterpoint

A PT cut with a maintained Buy can reflect a more conservative valuation framework rather than deteriorating fundamentals, so the market may discount it.

Key entities

  • Citigroup

    Reportedly adjusted its CRH price target to $122 from $138 and kept a Buy rating.

  • CRH

    Subject of the analyst price-target adjustment referenced in the article title.

Related articles

$CRHMedAI 8/10

CRH reports stronger 2Q26 earnings and reaffirms outlook

CRH reported 2Q26 revenues of US$10.8bn, up 6% year over year, and net income up 13% to US$1.5bn. Adjusted EBITDA rose 7% to US$2.6bn, with margins improving. CRH completed three non-core divestments and invested US$1.4bn in 17 acquisitions YTD, and agreed to buy Arcosa for US$8.5bn. It reaffirmed 2026 guidance: net income US$3.9-4.1bn, adjusted EBITDA US$8.1-8.5bn, EPS US$5.60-6.05.

$CRHMedAI 8/10

CRH's second quarter revenues up on pricing and demand

CRH reported Q2 2026 revenues up 6% to $10.8 billion, net income up 13% to $1.5 billion, adjusted EBITDA up 7% to $2.6 billion, and diluted EPS up 14% to $2.21, citing pricing momentum, demand, and acquisitions. The company reaffirmed full-year guidance and completed $1.1 billion of acquisitions and $1.7 billion of net divestiture proceeds.

$CRHHigh

CRH PUBLIC LTD CO (CRH): Results of Operations and Financial Condition

CRH PUBLIC LTD CO (CRH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2resultsannouncement2026.htm EX-99.1 Document Exhibit 99.1 CRH Reports Second Quarter 2026 Results • Strong quarter driven by good commercial management, favorable underlying demand and contributions from acquisitions • Increases in revenues, profits and margins reflec

$CRHHighAI 9/10

CRH to Buy Arcosa, Shares Skid

CRH said it will buy 100% of Arcosa in an all-cash deal for $150 per share, subject to Arcosa shareholder and regulatory approvals. The offer implies a 25% premium to Arcosa’s June 18 60-day VWAP. CRH values Arcosa at about $8.5B enterprise value (11.5x 2026E adj. EBITDA) and expects $175M annual synergies by year three.

$CRHHighAI 9/10

CRH To Acquire Arcosa For $150/share, Arcosa Up In Pre-market

CRH plc agreed to acquire Arcosa, Inc. for $150 per share in cash, valuing Arcosa at about $8.5 billion and implying a 25% premium to its 60-day VWAP as of June 18, according to CRH. CRH expects $175 million in annual run-rate cost synergies by year three and accretion within 12 months after closing, targeted for Q1 2027.